bioRASI
 
bioRASI serves North America, Europe and Asia
Recent News
bioRASI will Sponsor the Evolution Summit 2011, Oct 17 -19, 2011 in Montreux, Switzerland
bioRASI launched a Phase II Infectious Disease clinical study
bioRASI sponsored and exhibited at the GPhA Fall Technical Conference on October 3 5, 2011.
bioRASI launched a 1300 patient clinical endpoint, ANDA, Phase III dermatology study.
A Phase III endocrinology study conducted by bioRASI has been submitted by the sponsor to the FDA
read more

Everyday, in clinical settings around the world, leading biotech and pharmaceutical companies count on bioRASI to help optimize their clinical development programs.


bioRASI’s clients benefit from its access to patients and special populations in the U.S., Europe and Asia, to achieve unparalleled scientific, clinical and business results significantly faster and at lower costs.


bioRASI accelerates the process of obtaining FDA approvals with a full spectrum of services, including:


Program Optimization
Project Management
Regulatory
Clinical
Data Management & Analysis
Compliance & Audit


bioRASI is headquartered in Miami, FL and has regional offices, labs, and clinics across the U.S. and overseas.
flower and pills
bioRASI releases a series of white papers on clinical endpoint ANDA and 505(b)(2) Program Optimization Techniques.


To receive a copy...

eye dropper
 

F u l l   S e r v i c e   G l o b a l   C R O